Renal and systemic acid-base effects of the chronic administration of hypercalcemia-producing agents

Calcitriol, PTH, and intravenous calcium

H. N. Hulter, A. Sebastian, R. D. Toto, E. L. Bonner, L. P. Ilnicki

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Balance studies were performed in dogs to characterize the systemic and renal acid-base response to chronic administration of hypercalcemia-producing agents of diverse chemical nature and mechanism of calcemic action. In thyroparathyroidectomized (TPTX) dogs (group 1, N = 6), chronic oral administration of 1,25-dihydroxycholecalciferol (1,25-(OH)2D3; calcitriol) resulted in sustained hypercalcemia and chloride-resistant metabolic alkalosis. Urinary net acid excretion (NAE) remained unchanged. Therefore, the increase in steady-state plasma bicarbonate concentration was independent of the endogenous change in the parathyroid hormone (PTH) and was in part of extrarenal origin because NAE did not increase and in part of renal origin because NAE did not decrease. In response to 1,25-(OH)2D3 metabolic alkalosis also occurred in dogs ingesting a low Pi diet (group 2, N = 5) and in dogs that received Pi supplements (group 4, N = 6), but in the former group there was a hypophosphaturic limitation on titratable acid excretion and a decrease in NAE, whereas in the latter group, there was a hyperphosphaturic accentuation of titratable acid excretion and an increase in NAE. Significant increases in plasma bicarbonate concentration and decreases in hydrogen ion concentration also occurred in intact dogs administered large doses of PTH by intermittent injection for 7 days (group 5, N = 6). In this group, as in the TPTX dogs of group 1 administered 1,25-(OH)2D3, the changes in systemic acid-base composition occurred in the absence of either increases or decreases in NAE. Thus, chronic PTH administration as well as 1,25-(OH)2D3 administration (group 1) resulted in metabolic alkalosis attributable to both extrarenal and renal mechanisms. Maintenance of the metabolic alkalosis, however generated, is inferred to be predominantly dependent on the renal effects of 1,25-(OH)2D3 and PTH because without administration of these agents chronic extrarenal alkali input to both normal and TPTX dogs did not result in metabolic alkalosis. In TPTX dogs with chronic hypercalcemia induced by administration of increasing amounts of calcium in substitution for sodium in a continuous intravenous infusion (group 8, N = 3), the plasma bicarbonate concentration decreased and the hydrogen ion concentration increased significantly in association with an increase in NAE. Thus, metabolic acidosis of extrarenal origin occurred and persisted with a directionally appropriate renal homeostatic response. Taken together, the results of the present studies thus suggest that the movement of calcium to or from extracellular fluid (ECF) and bone (and/or soft tissue) in response to hypercalcemia-producing agents is accompanied by a directionally similar movement of base equivalents which results in either metabolic acidosis or alkalosis depending on the direction of net movement of calcium: (1) Calcium infusion → base deposition in bone/soft tissue → metabolic acidosis; (2) 1,25-(OH)2D3 or PTH administration → base release from bone → metabolic alkalosis. Moreover, chronic 1,25-(OH)2D3 or PTH administration increases the set point at which the plasma bicarbonate concentration is regulated by the kidney and thereby causes metabolic alkalosis to persist.

Original languageEnglish (US)
Pages (from-to)445-458
Number of pages14
JournalKidney International
Volume21
Issue number3
StatePublished - 1982

Fingerprint

Calcitriol
Hypercalcemia
Parathyroid Hormone
Alkalosis
Calcium
Kidney
Acids
Dogs
Bicarbonates
Acidosis
Bone and Bones
Extracellular Fluid
Base Composition
Alkalies
Intravenous Infusions
Oral Administration
Chlorides
Sodium
Maintenance
Diet

ASJC Scopus subject areas

  • Nephrology

Cite this

Renal and systemic acid-base effects of the chronic administration of hypercalcemia-producing agents : Calcitriol, PTH, and intravenous calcium. / Hulter, H. N.; Sebastian, A.; Toto, R. D.; Bonner, E. L.; Ilnicki, L. P.

In: Kidney International, Vol. 21, No. 3, 1982, p. 445-458.

Research output: Contribution to journalArticle

@article{4579b22878af472ba78391a6543501e3,
title = "Renal and systemic acid-base effects of the chronic administration of hypercalcemia-producing agents: Calcitriol, PTH, and intravenous calcium",
abstract = "Balance studies were performed in dogs to characterize the systemic and renal acid-base response to chronic administration of hypercalcemia-producing agents of diverse chemical nature and mechanism of calcemic action. In thyroparathyroidectomized (TPTX) dogs (group 1, N = 6), chronic oral administration of 1,25-dihydroxycholecalciferol (1,25-(OH)2D3; calcitriol) resulted in sustained hypercalcemia and chloride-resistant metabolic alkalosis. Urinary net acid excretion (NAE) remained unchanged. Therefore, the increase in steady-state plasma bicarbonate concentration was independent of the endogenous change in the parathyroid hormone (PTH) and was in part of extrarenal origin because NAE did not increase and in part of renal origin because NAE did not decrease. In response to 1,25-(OH)2D3 metabolic alkalosis also occurred in dogs ingesting a low Pi diet (group 2, N = 5) and in dogs that received Pi supplements (group 4, N = 6), but in the former group there was a hypophosphaturic limitation on titratable acid excretion and a decrease in NAE, whereas in the latter group, there was a hyperphosphaturic accentuation of titratable acid excretion and an increase in NAE. Significant increases in plasma bicarbonate concentration and decreases in hydrogen ion concentration also occurred in intact dogs administered large doses of PTH by intermittent injection for 7 days (group 5, N = 6). In this group, as in the TPTX dogs of group 1 administered 1,25-(OH)2D3, the changes in systemic acid-base composition occurred in the absence of either increases or decreases in NAE. Thus, chronic PTH administration as well as 1,25-(OH)2D3 administration (group 1) resulted in metabolic alkalosis attributable to both extrarenal and renal mechanisms. Maintenance of the metabolic alkalosis, however generated, is inferred to be predominantly dependent on the renal effects of 1,25-(OH)2D3 and PTH because without administration of these agents chronic extrarenal alkali input to both normal and TPTX dogs did not result in metabolic alkalosis. In TPTX dogs with chronic hypercalcemia induced by administration of increasing amounts of calcium in substitution for sodium in a continuous intravenous infusion (group 8, N = 3), the plasma bicarbonate concentration decreased and the hydrogen ion concentration increased significantly in association with an increase in NAE. Thus, metabolic acidosis of extrarenal origin occurred and persisted with a directionally appropriate renal homeostatic response. Taken together, the results of the present studies thus suggest that the movement of calcium to or from extracellular fluid (ECF) and bone (and/or soft tissue) in response to hypercalcemia-producing agents is accompanied by a directionally similar movement of base equivalents which results in either metabolic acidosis or alkalosis depending on the direction of net movement of calcium: (1) Calcium infusion → base deposition in bone/soft tissue → metabolic acidosis; (2) 1,25-(OH)2D3 or PTH administration → base release from bone → metabolic alkalosis. Moreover, chronic 1,25-(OH)2D3 or PTH administration increases the set point at which the plasma bicarbonate concentration is regulated by the kidney and thereby causes metabolic alkalosis to persist.",
author = "Hulter, {H. N.} and A. Sebastian and Toto, {R. D.} and Bonner, {E. L.} and Ilnicki, {L. P.}",
year = "1982",
language = "English (US)",
volume = "21",
pages = "445--458",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Renal and systemic acid-base effects of the chronic administration of hypercalcemia-producing agents

T2 - Calcitriol, PTH, and intravenous calcium

AU - Hulter, H. N.

AU - Sebastian, A.

AU - Toto, R. D.

AU - Bonner, E. L.

AU - Ilnicki, L. P.

PY - 1982

Y1 - 1982

N2 - Balance studies were performed in dogs to characterize the systemic and renal acid-base response to chronic administration of hypercalcemia-producing agents of diverse chemical nature and mechanism of calcemic action. In thyroparathyroidectomized (TPTX) dogs (group 1, N = 6), chronic oral administration of 1,25-dihydroxycholecalciferol (1,25-(OH)2D3; calcitriol) resulted in sustained hypercalcemia and chloride-resistant metabolic alkalosis. Urinary net acid excretion (NAE) remained unchanged. Therefore, the increase in steady-state plasma bicarbonate concentration was independent of the endogenous change in the parathyroid hormone (PTH) and was in part of extrarenal origin because NAE did not increase and in part of renal origin because NAE did not decrease. In response to 1,25-(OH)2D3 metabolic alkalosis also occurred in dogs ingesting a low Pi diet (group 2, N = 5) and in dogs that received Pi supplements (group 4, N = 6), but in the former group there was a hypophosphaturic limitation on titratable acid excretion and a decrease in NAE, whereas in the latter group, there was a hyperphosphaturic accentuation of titratable acid excretion and an increase in NAE. Significant increases in plasma bicarbonate concentration and decreases in hydrogen ion concentration also occurred in intact dogs administered large doses of PTH by intermittent injection for 7 days (group 5, N = 6). In this group, as in the TPTX dogs of group 1 administered 1,25-(OH)2D3, the changes in systemic acid-base composition occurred in the absence of either increases or decreases in NAE. Thus, chronic PTH administration as well as 1,25-(OH)2D3 administration (group 1) resulted in metabolic alkalosis attributable to both extrarenal and renal mechanisms. Maintenance of the metabolic alkalosis, however generated, is inferred to be predominantly dependent on the renal effects of 1,25-(OH)2D3 and PTH because without administration of these agents chronic extrarenal alkali input to both normal and TPTX dogs did not result in metabolic alkalosis. In TPTX dogs with chronic hypercalcemia induced by administration of increasing amounts of calcium in substitution for sodium in a continuous intravenous infusion (group 8, N = 3), the plasma bicarbonate concentration decreased and the hydrogen ion concentration increased significantly in association with an increase in NAE. Thus, metabolic acidosis of extrarenal origin occurred and persisted with a directionally appropriate renal homeostatic response. Taken together, the results of the present studies thus suggest that the movement of calcium to or from extracellular fluid (ECF) and bone (and/or soft tissue) in response to hypercalcemia-producing agents is accompanied by a directionally similar movement of base equivalents which results in either metabolic acidosis or alkalosis depending on the direction of net movement of calcium: (1) Calcium infusion → base deposition in bone/soft tissue → metabolic acidosis; (2) 1,25-(OH)2D3 or PTH administration → base release from bone → metabolic alkalosis. Moreover, chronic 1,25-(OH)2D3 or PTH administration increases the set point at which the plasma bicarbonate concentration is regulated by the kidney and thereby causes metabolic alkalosis to persist.

AB - Balance studies were performed in dogs to characterize the systemic and renal acid-base response to chronic administration of hypercalcemia-producing agents of diverse chemical nature and mechanism of calcemic action. In thyroparathyroidectomized (TPTX) dogs (group 1, N = 6), chronic oral administration of 1,25-dihydroxycholecalciferol (1,25-(OH)2D3; calcitriol) resulted in sustained hypercalcemia and chloride-resistant metabolic alkalosis. Urinary net acid excretion (NAE) remained unchanged. Therefore, the increase in steady-state plasma bicarbonate concentration was independent of the endogenous change in the parathyroid hormone (PTH) and was in part of extrarenal origin because NAE did not increase and in part of renal origin because NAE did not decrease. In response to 1,25-(OH)2D3 metabolic alkalosis also occurred in dogs ingesting a low Pi diet (group 2, N = 5) and in dogs that received Pi supplements (group 4, N = 6), but in the former group there was a hypophosphaturic limitation on titratable acid excretion and a decrease in NAE, whereas in the latter group, there was a hyperphosphaturic accentuation of titratable acid excretion and an increase in NAE. Significant increases in plasma bicarbonate concentration and decreases in hydrogen ion concentration also occurred in intact dogs administered large doses of PTH by intermittent injection for 7 days (group 5, N = 6). In this group, as in the TPTX dogs of group 1 administered 1,25-(OH)2D3, the changes in systemic acid-base composition occurred in the absence of either increases or decreases in NAE. Thus, chronic PTH administration as well as 1,25-(OH)2D3 administration (group 1) resulted in metabolic alkalosis attributable to both extrarenal and renal mechanisms. Maintenance of the metabolic alkalosis, however generated, is inferred to be predominantly dependent on the renal effects of 1,25-(OH)2D3 and PTH because without administration of these agents chronic extrarenal alkali input to both normal and TPTX dogs did not result in metabolic alkalosis. In TPTX dogs with chronic hypercalcemia induced by administration of increasing amounts of calcium in substitution for sodium in a continuous intravenous infusion (group 8, N = 3), the plasma bicarbonate concentration decreased and the hydrogen ion concentration increased significantly in association with an increase in NAE. Thus, metabolic acidosis of extrarenal origin occurred and persisted with a directionally appropriate renal homeostatic response. Taken together, the results of the present studies thus suggest that the movement of calcium to or from extracellular fluid (ECF) and bone (and/or soft tissue) in response to hypercalcemia-producing agents is accompanied by a directionally similar movement of base equivalents which results in either metabolic acidosis or alkalosis depending on the direction of net movement of calcium: (1) Calcium infusion → base deposition in bone/soft tissue → metabolic acidosis; (2) 1,25-(OH)2D3 or PTH administration → base release from bone → metabolic alkalosis. Moreover, chronic 1,25-(OH)2D3 or PTH administration increases the set point at which the plasma bicarbonate concentration is regulated by the kidney and thereby causes metabolic alkalosis to persist.

UR - http://www.scopus.com/inward/record.url?scp=0020055715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020055715&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 445

EP - 458

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 3

ER -